Consensus
The community is moderately leaning bullish on Sanofi at 60%, based on 6 forecasts. Forecasters are in moderate agreement.
Resolves YES if Sanofi's price 12 months out is above its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole sny discussion →